Evidence map›Paper›PMID 41981042›Full record

ArticleScientific reports2026

Optimizations on multi-mineral clayey soil to develop limestone calcined clay cement (LC3) based composite.

Arass Omer Mawlod, Aram Aziz

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arass Omer MawlodCivil Engineering Department, College of Engineering, University of Raparin, Ranya, Kurdistan, Iraq. arass.omer@uor.edu.krd.
Aram AzizDepartment of Petroleum Engineering, Faculty of Engineering, Koya University, Kurdistan Region-F, Koya, 44023, Kurdistan Region-F.R., Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cement industry plays a significant role in contributing to global carbon dioxide emissions, representing a considerable portion of the total environmental impact. In response to growing environmental concerns, supplementary cementitious materials such as calcined clay and limestone have gained prominence due to their abundance and reduced carbon footprint. Among these, limestone calcined clay cement (LC3) has emerged as a promising sustainable alternative to ordinary Portland cement (OPC). This study investigates the feasibility of utilizing locally available non-kaolinitic clayey soil in the development of LC3-based binders. The research was conducted in two phases: initially, the optimum calcination temperature, substitution level of calcined clay, and calcined clay-to-limestone ratio (CC: LS) were determined, yielding optimal values of 650 °C, 30%, and 2:1, respectively. Subsequently, the optimal binder compositions were reinforced with recycled sheep wool (Wl) and (PP) fibers at varying dosages of 0, 0.5, 1, and 1.5% by binder weight. Fresh mortar flowability was assessed, followed by evaluation of mechanical properties, including compressive strength, flexural strength, and splitting tensile strength. Durability parameters such as fire resistance, water absorption, water sorptivity, and porosity were also examined. The results indicated that fiber additions of 1.5% Wl and 1% PP offered the best balance of mechanical performance and durability. However, increasing fiber content consistently reduced flowability. Overall, the findings demonstrate the viability of using locally sourced clayey soil as a pozzolanic material in LC3 production and highlight LC3 potential as a sustainable structural material.

Indexed as

Calcined clayFire resistanceFlowabilityLimestone calcined clay cementSplitting tensile strength

Identifiers

PMID41981042
PMCPMC13237236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.